GLP-1 Constipation: What Helps
Constipation showed up in about 1 in 4 people on semaglutide in the trials. Why GLP-1s cause it, what actually helps, and the symptoms that mean you should call.
Medically supervised GLP-1 protocols, what to expect month by month, and how to protect muscle while you lose fat. Evidence-based weight loss guidance from Defiant Health.
Constipation showed up in about 1 in 4 people on semaglutide in the trials. Why GLP-1s cause it, what actually helps, and the symptoms that mean you should call.
Semaglutide is now FDA-approved for MASH with fibrosis. What the ESSENCE and SYNERGY-NASH trials found, and how much of the liver benefit is really the weight loss.
For most people, yes, by about 5 to 10 mmHg, mostly from the weight loss. What the trials found, why the real effect is bigger than the average, and why not to touch your own BP meds.
The research points the other way: in the kidney trials, GLP-1s slowed disease progression. The real risk is dehydration. What FLOW found, who should be careful, and why your eGFR can mislead.
None of them give you your true body fat percentage. How DEXA, 3D optical scanning, and InBody compare on accuracy and repeatability, and which one to track a GLP-1 with.
In the trials, most people with prediabetes on a GLP-1 returned to normal blood sugar. What the numbers show on and off treatment, and why it is not FDA-approved for this.
Some people shed around month four, and it's usually temporary. What the semaglutide and tirzepatide labels report, why women lose far more, and why the timing fools everyone.
Your first consultation is mostly a conversation: your weight and medical history, the labs, a body scan, and a straight answer on whether a GLP-1 protocol is right for you.
Semaglutide cut major cardiac events 20% in the SELECT trial, but every participant already had heart disease. What the evidence shows, and why it probably isn't about you.
No peptide is proven to make tirzepatide work better, and the combination hasn't been studied. An honest look at what actually protects your muscle, and where peptides really fit.
GLP-1s cut CRP by 39 to 65% in the big trials. What those inflammation numbers actually mean, and the honest answer on whether it's the drug or the weight loss doing the work.
Fatigue hit 11% of adults on semaglutide in trials, and it usually traces to something fixable: too few calories, low protein, mild dehydration, or low vitamin D, iron, or B12.
Abdomen, thigh, or upper arm, and the FDA labels report similar absorption across all three. Why rotating the exact spot matters more than which region you pick.
Not all GLP-1 weight loss is fat. What the DXA trial data shows about fat versus lean mass, why lean loss isn't GLP-1-specific, and how Defiant tracks it monthly in Lisle.
In December 2024 tirzepatide became the first drug FDA-approved for moderate-to-severe sleep apnea in adults with obesity. What the SURMOUNT-OSA trial found, and what it doesn't mean for CPAP.
GLP-1s don't cause loose skin, the weight loss does. What actually drives it, what may reduce it during the losing phase, and what removes it, near Lisle.
A BMI of 30, or 27 with a weight-related condition like prediabetes or sleep apnea. The criteria behind semaglutide and tirzepatide, and how a provider confirms it.
Protein first, smaller portions, slower meals. A practical guide to eating well on semaglutide or tirzepatide, plus the foods that tend to cause trouble.
Food noise is the constant mental chatter about eating. Here's how semaglutide and tirzepatide may turn it down, and why it's biology, not willpower.
Your GLP-1 stalled? A plateau is usually a normal, fixable stage. Why stalls happen, how to tell a real one from a weekly wobble, and what a program adjusts first.
Most people regain a large share of the weight after stopping. What the withdrawal trials show, why it happens, and how to plan the off-ramp instead of pretending it does not exist.
Midlife weight gain is hormonal, not willpower. How declining estrogen changes your metabolism, and how medically supervised GLP-1 protocols may help while protecting muscle.
A week-by-week guide to starting semaglutide or tirzepatide: starter doses, appetite changes, side effects, and when your dose moves up.
The peptides that drive weight loss are the GLP-1 class. Here is what the research shows, and what sermorelin, tesamorelin, and the other peptides actually do.
Up to 40% of weight lost on a GLP-1 can come from lean mass. The protein, training, and tracking protocol Defiant uses to protect what you've built.
Mechanism, trial results, side effects, cost, and how we decide between them at Defiant. Custom GLP-1 protocols from $295/mo.
Longevity tips, recovery science, and what’s working at the clinic.
Unsubscribe anytime. We don’t share your email.